Citations

Clear

367 citation(s) found for "Benson, Al".

Aberrant ICA and Associated Skull Base Foramina Visualized on Photon Counting Detector CT: Interesting Images
Sadaney, Ahmed O El , Lane, John I. , El Sadaney, Ahmed O , Benson, John C. , Lane, John I , Farnsworth, Paul J. , Diehn, Felix E.

Mayo Clinic

Diagnostics | September 1, 2025 | Volume: 15 | Issue: 17 | Pages: 2213

10.3390/diagnostics15172213 | PMID 40941700 Get It

Aberrant internal carotid arteries (ICA) are congenital vascular anomalies that occur from involution of the cervical portion of the ICA, which leads to enlargement of the normally small collateral inferior tympanic and caroticotympanic arteries. The inferior tympanic artery is a branch of the external carotid artery, usually the ascending pharyngeal artery, which extends through the inferior tympanic canaliculus (ITC), a small foramen located along the cochlea promontory. Aberrant ICAs can also be associated with a persistent stapedial artery (PSA), which is an abnormal vessel that arises from the petrous ICA and passes through the obturator foramen of the stapes. An aberrant ICA is a very important anomaly to recognize on imaging. Accurately describing its presence is important to help prevent iatrogenic injury during intervention. It is also important to distinguish an aberrant ICA from a lateralized ICA. The improvement of spatial resolution with photon counting detector (PCD)-CT has been proven to provide higher performance in detection of sub-centimeter vascular lesions compared to conventional energy-integrated detector (EID)-CT. PCD-CT also provides superior visualization of small skull-based foramina such as the inferior tympanic canaliculus, which can aid in more accurately characterizing an aberrant ICA (variant course without ITC involvement).
Recognition and Management of Iatrogenically Induced Opioid Dependence and Withdrawal in Children: Clinical Report
Siegel, Linda, Wilder, Robert T. , Good, Julie , Reigart, J. Routt, Eckstein, Olive S. , Hindman, Diane E., Verhoef, Philip A. , Watt, Kevin , Care, Section on Critical, Hsu, Benson, Huh, Jimmy W. , Lowrie, Lia, Ndely, Simon-Noel, Satchell, Margaret A., Medicine, Section on Anesthesiology and Pain, Chatterjee, Debnath , Diaz, Christina, Drum, Elizabeth T. , Sun, Lena S. , Willer, Brittany L. , Landrigan‐Ossar, Mary, Adler, Adam C. , Goldman, Jennifer L. , Hindman, Diane E., Care, Section on Critical, Ndely, Simon-Noel, Srinivasan, Vijay , Medicine, Section on Anesthesiology and Pain, Long, Justin B.

Mayo Clinic

Pediatrics | August 18, 2025 | Volume: 156 | Issue: 3 | Pages: No page available

10.1542/peds.2025-073169 | PMID 40819838 Get It

Opioids are often prescribed to children for pain relief related to procedures, acute injuries, and chronic conditions. Around-the-clock dosing of opioids can produce physiologic opioid dependence within 5 days. According to a 2001 consensus paper from the American Academy of Pain Medicine, American Pain Society, and American Society of Addiction Medicine, dependence is defined as “a state of adaptation that is manifested by a drug class specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, or administration of an antagonist.” The experience of children undergoing iatrogenic withdrawal symptoms is variable and may be mild and go unreported or can be severe and even life threatening. Guidance on opioid withdrawal is available only for adults and primarily for adults with substance use disorders. This report will summarize existing literature and provide readers with information on how to screen for symptoms of iatrogenic opioid withdrawal as well as mechanisms for opioid withdrawal prevention.
Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients
Morray, Brian H. , Gillespie, Matthew J. , Cheatham, John P. , Salavitabar, Arash , Peng, Lynn F., Jones, Thomas K. , Levi, Daniel S. , Gray, Robert G. , Asnes, Jeremy D. , Cabalka, Allison K. , Fujimoto, Kazuto , Qureshi, Athar M. , Bergersen, Lisa, Haugan, Daniel, McElhinney, Doff B. , Asnes, Jeremy D , Benson, Lee N. , McElhinney, Doff B , Jones, Thomas K , Morray, Brian H , Cabalka, Allison , Bergersen, Lisa

Mayo Clinic

Circulation: Cardiovascular Interventions | July 16, 2025 | Volume: 18 | Issue: 9 | Pages: No page available

10.1161/circinterventions.125.015196 | PMID 40665900 Get It

BACKGROUND: The Harmony transcatheter pulmonary valve (TPV) is designed to treat severe pulmonary regurgitation in the native or surgically repaired right ventricular (RV) outflow tract. Early outcomes after TPV replacement with the Harmony valve have been positive, but longer-term data are limited. METHODS: The study included patients who received a commercially available TPV22 or TPV25 device as part of the nonrandomized, prospective Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study. Patients completed at least 3 years of follow-up, and outcomes to 5 years were reported when available. RESULTS: Eighty-nine patients were catheterized, and 86 were successfully implanted with a Harmony TPV. Median duration of follow-up was 5 (range 0–6) years in the TPV22 group and 3 (1–4) years in the TPV25 group. At 3 years, all patients with a TPV22 and 96% of those with a TPV25 had ≤mild pulmonary regurgitation. By magnetic resonance imaging, significant improvements from preimplant to 2 years were observed in RV end-diastolic volume index, RV to left ventricular end-diastolic volume ratio, and effective RV stroke volume (all P <0.001). SF-36 quality-of-life scores improved after Harmony implantation and were sustained over 3 years. Early cases of ventricular tachycardia resolved, and there were no new arrhythmias. Adverse events up to 5 years included 3 deaths unrelated to the device or procedure, 2 cases of endocarditis that were treated (1 medically, 1 transcatheter debulking of a vegetation) and resolved, 6 patients with RV outflow tract obstruction or thrombosis resulting in valve-in valve procedures, and 1 major stent fracture resulting in surgical explant. CONCLUSIONS: At 3 to 5 years, Harmony TPV replacement resulted in sustained valve competence, beneficial cardiac remodeling, and improved quality of life. Continued monitoring is needed to assess long-term outcomes and valve performance. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01762124; NCT02979587.
Supporting the Deceased, Their Families, and Their Communities – Part 2: Practical Guidance for Building an Office of Decedent Affairs
Chambers, Meagan , Bartholow, Tanner, Parker, Zachary T., Peters, Kristina, Reichard, R. Ross , Tigard, Charles, Hooper, Jody E. , Benson, Paul , Davis, Ronnie, Cool, Robert, Beglarian, Ben, Mount, Sharon , Jackson, Nicole R. , Marshall, Desiree A. , Harcourt, Lisbeth, Wiley, LaTresa E., Comstock, Jessica, Hyland, Courtney, Harper, Holly , Priemer, David S. , Rapkiewicz, Amy , Rojiani, Amyn M. , Sanchez, Harold, Parker, Zachary T., Peters, Kristina, Luthringer, Daniel , Davis, Ronnie, Scherpelz, Kathryn P. , Sinard, John H. , Chen, Sonja

Mayo Clinic

Archives of Pathology & Laboratory Medicine | July 8, 2025 | Volume: 149 | Issue: 12 | Pages: 1077-1083

10.5858/arpa.2025-0094-oa | PMID 40626859 Get It

Context.— After-death care can be complicated and time-consuming for clinical staff, and frustrating for bereaved families. Delays and errors can have damaging legal and reputational consequences for hospitals. Offices of Decedent Affairs (ODAs) have been proposed as a solution, and their potential benefits have been described in several single institution reports. The literature lacks a contemporary and comprehensive review of existing ODAs and their approaches. Objective.— To describe the process of establishing a new ODA and to provide a snapshot of the spectrum of structure, function, and impact of existing ODAs in the United States. Design.— A survey was administered to 11 established ODAs spread across the continental United States. Programs were identified through the College of American Pathologists Autopsy Committee and a Medical Autopsy Listserv. Results.— Eleven ODAs returned the survey, representing more than 190 cumulative years of experience in decedent care in the hospital setting (median, 10 years). There was a wide range in staffing (both staff size and background) as well as scope of services offered. The median ratio of hospital deaths to full-time equivalent (FTE) staffing was 360 deaths per FTE. Respondents reported that ODAs unburden clinical providers and facilitate decedent management. Some respondents reported a quicker turnover of hospital beds and shorter intervals between pronouncement of death and autopsy. ODAs increased autopsy rates when the autopsy services were part of the ODA. Conclusions.— This survey provides practical information for hospitals considering establishing a new ODA and useful benchmarks for existing ODA programs.
Supporting the Deceased, Their Families, and Their Communities – Part 1: Why Establish an Office of Decedent Affairs
Chambers, Meagan , Bartholow, Tanner, Parker, Zachary T., Peters, Kristina, Reichard, R. Ross , Tigard, Charles, Hooper, Jody E. , Benson, Paul , Davis, Ronnie, Cool, Robert, Beglarian, Ben, Mount, Sharon , Jackson, Nicole R. , Marshall, Desiree A. , Harcourt, Lisbeth, Wiley, LaTresa E., Comstock, Jessica, Hyland, Courtney, Harper, Holly , Priemer, David S. , Rapkiewicz, Amy , Rojiani, Amyn M. , Sanchez, Harold, Parker, Zachary T., Peters, Kristina, Luthringer, Daniel , Davis, Ronnie, Scherpelz, Kathryn P. , Sinard, John H. , Chen, Sonja

Mayo Clinic

Archives of Pathology & Laboratory Medicine | July 8, 2025 | Volume: 149 | Issue: 12 | Pages: 1072-1076

10.5858/arpa.2025-0090-oa | PMID 40626861 Get It

Context.— Decedent Affairs Offices and Programs can serve as an avenue to assist medical centers in facilitating efficient and comprehensive decedent management, despite a paucity of literature on their roles, establishment, and efficacy. Objective.— To characterize the motivations and rationales for establishing Decedent Affairs Offices. Design.— A survey was administered to 11 established Decedent Affairs Offices/Programs, identified through the College of American Pathologists Autopsy Committee and a Medical Autopsy Listserv. The questions comprehensively cover establishment, operations, and outcomes data available by institution. Results.— Survey respondents reported the rationale for starting their programs and the benefits such offices can have. Conclusions.— Decedent Affairs Offices and Programs provide a useful option to medical centers to navigate the increasingly complex task of comprehensive decedent management. The present survey helps to delineate the similarities and differences between these programs at 11 institutions, to aid nascent programs in their establishment and growth over time.
New Imaging Modality in Craniocervical Artery Dissections: Photon Counting Computed Tomography Angiography
Keser, Zafer , Xeros, Helena , Sadaney, Ahmed O El , Benson, John C. , Madhavan, Ajay A. , Lanzino, Giuseppe , Diehn, Felix E. , Xeros, Helena K , Thompson, Grace E, El Sadaney, Ahmed O , Benson, John , Madhavan, Ajay A , Lanzino, Giuseppe , Diehn, Felix E , Keser, Zafer , Thompson, Grace E.

Mayo Clinic

Journal of the American Heart Association | June 16, 2025 | Volume: 14 | Issue: 12 | Pages: No page available

10.1161/jaha.125.041628 | PMID 40519210 Get It

Is retirement a pain in the back? A 23-year population-based study on the impact of age and employment on spinal injections
Faghani, Shahriar , Moassefi, Mana, McDonald, Jennifer S, Benson, John C. , Benson, John , Faghani, Shahriar , Moassefi, Mana , McDonald, Jennifer S, Erickson, Bradley J.

Mayo Clinic

The Neuroradiology Journal | May 30, 2025 | Volume: 39 | Issue: 1 | Pages: 105-110

10.1177/19714009251345115 | PMID 40443233 Get It

Purpose Spine-related pain disorders commonly require interventions such as spinal injections, which are often image-guided and increase in demand as populations age. This study investigates the impact of lifestyle changes following retirement on the incidence of these procedures, hypothesizing that retirement significantly influences the requirement for such treatments. Methods A review of medical records from XXX County between 2000 and 2023 was conducted, focusing on patients who received spinal injections, including epidural steroid, facet, and sacroiliac joint injections. Data were stratified by age, employment status pre- and post-procedure, and type of injection. Statistical analysis, including segmental linear regression and t-tests, was used to assess changes in incidence rates over time and across demographic subsets. Results Out of 134,318 patients analyzed, a total of 359,224 spinal injections were performed. There was a significant ( p -value <.01) increase in the frequency of procedures among individuals around the age of 60, which coincides with the typical retirement age in the United States. The study also highlighted a subsequent decline in the incidence of these procedures between the ages of 70 and 74, suggesting potential adaptation to chronic conditions or the effectiveness of earlier treatments. Conclusion The findings of this study confirm the hypothesis that retirement significantly impacts the demand for spinal injections, as evidenced by the marked increase in procedures at typical retirement ages. This underscores the importance of integrating preventive care and personalized medical guidance into healthcare strategies for individuals nearing retirement to effectively manage spine-related pain disorders and reduce the necessity for invasive treatments.
Reduced length of stay as an alternative to full outpatient CAR-T services.
Benson, Hollie, Torabi, Yeganeh, Foreman, John W., John, Sunny St, Yennie, Julia, Wilson, CiCi N, Rosenthal, Allison , Foreman, John, John, Sunny St, Wilson, CiCi N

Mayo Clinic

Journal of Clinical Oncology | May 28, 2025 | Volume: 43 | Issue: 16_suppl | Pages: No page available

10.1200/jco.2025.43.16_suppl.e13575 Get It

e13575 Background: Cellular therapies continue to expand in diversity, complexity, and financial impact leading clinicians and administrators to seek innovative care options. The paradigm of late has been to move to an outpatient treatment model. However, centers may not find this model to be the safest option for their patients. This pilot project aims to use established outpatient resources to reduce hospital length of stay (LOS) for patients receiving ciltacabtagene autoleucel in an inpatient setting. Methods: Chart review was conducted for 42 patients treated for incidence of CRS, days to onset, LOS, readmissions, and hospital expenses and charges. The cohort showed an 83% incidence of CRS with a mean onset of 7 days. 71% of CRS was limited to Grade 1. The mean LOS was 10.8 days and the readmission rate was 21%. Financial modeling estimated overall cost reduction to range from $13,000 to $20,000 per patient for a LOS of 3 days. A pilot project to reduce LOS was developed with inclusion/exclusion criteria prioritizing patient safety and likelihood of remaining in the outpatient setting. A workflow for administering one dose of tocilizumab for Grade 1 CRS in the outpatient setting was also established to counterbalance readmissions. The goal of the pilot is to reduce the overall LOS from 10 days to 3 days while maintaining readmission rates and comparable charge to reimbursement ratios on net operating income. Results: In the first five months, 25 patients were screened for eligibility. 60% were deemed eligible and 66% of those were discharged after three days. No patients discharged after a minimum admission were readmitted within three days. Current data suggests the readmission rate within 30 days is higher than baseline at 40%. The overall LOS of patients enrolled in the pilot upon infusion was six days. Patients successfully remaining on the pilot have a 60% reduction in LOS. There have been no major safety events. Conclusions: We identified that select patients could be managed in the outpatient setting after a minimum three-midnight hospital admission. A pilot project was developed using our comprehensive care model coupled with a minimum LOS of 3 days. After discharge, patients are followed daily in our outpatient clinic using in-person visits and remote patient monitoring. To counterbalance readmissions, Grade 1 CRS has been treated in the outpatient clinic including administration of tocilizumab. Early data indicates that the workflow is reducing LOS by 60% under patient selection criteria capturing approximately 60% of patients. While readmissions in the first three days post discharge have been parried, there is opportunity to further reduce readmissions in the first 30 days following CAR-T infusion. We anticipate the pilot will reduce costs without negatively impacting reimbursement or readmissions.
Allele-specific vitamin D receptor binding is associated with pediatric-onset multiple sclerosis
Yilmaz, Defne , Adams, Cameron , Francisco, Carla , Rutatangwa, Alice , Quach, Hong , Quach, Diana , Aaen, Gregory , Lotze, Timothy , Mar, Soe , Ness, Jayne , Wheeler, Yolanda , Gorman, Mark , Schreiner, Teri , Tillema, Jan-Mendelt , Rose, John , Casper, T. Charles , Barcellos, Lisa F. , Edwards, Alice Rutatangwa , Benson, Leslie A , Weinstock‐Guttman, Bianca , Schreiner, Teri , Rensel, Mary R. , Horton, Mary , Graves, Jennifer , Benson, Leslie , Waldman, Amy , Tillema, Jan‐Mendelt , Chitnis, Tanuja , Waubant, Emmanuelle L.

Mayo Clinic

Multiple Sclerosis Journal – Experimental, Translational and Clinical | May 27, 2025 | Volume: 11 | Issue: 2 | Pages: No page available

10.1177/20552173251335625 | PMID 40438528 Get It

Background and Objectives The genetic basis of adult-onset multiple sclerosis (MS) is well-studied, but less is known about pediatric-onset MS (pedMS), comprising approximately 5% of all MS onsets. Mendelian randomization (MR) studies have demonstrated evidence for a causal association between MS and both 25-hydroxyvitamin D [25(OH)D] serum levels and genetic variation related to vitamin D receptor (VDR) binding. The objective was to identify whether VDR binding variants (VDR-BVs) previously implicated in adult-onset MS were associated with pedMS using genetic instrumental variables (GIVs). Methods Using previously identified VDR-BVs to construct individual GIVs with two-sample MR, we investigated associations with pedMS in 725 cases and 592 controls of European ancestry from the US Network of Pediatric MS Centers. Associations between each VDR-BV and pedMS were estimated using logistic regression adjusting for the first three genome-wide principal components. A significant interaction between a VDR-BV and 25(OH)D GIV provided evidence for a causal association unbiased by pleiotropy. Results One VDR-BV, rs2531804, previously associated with adult-onset MS, was also significantly associated with pedMS after multiple testing correction. Discussion This study is the first to use VDR-BVs from previous MR studies to demonstrate causal differences in VDR binding at a locus contributing to pedMS susceptibility.